Irina V. Vedenina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irina V. Vedenina has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Sergey V. Sviridov
Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia
5 shared publications - Kirill Yuryevich Krylov
Pirogov Russian National Research Medical University; N.N. Burdenko National medical research center of neurosurgery
4 shared publications - Mohan Rubanes
Peoples’ Friendship University of Russia (RUDN University)
2 shared publications - Ruben S. Yagubyan
Federal State Budgetary Scientific Institution “Federal Research and Clinical Center for Resuscitation and Rehabilitology”; The Russian National Research Medical University named after N.I. Pirogov
2 shared publications - Alexey N. Vorobyev
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
1 shared publication - Andrey A. Manevskiy
The Russian National Research Medical University named after N.I. Pirogov
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (4) , 168-178
Issues of diagnosis and correction of hypomagnesemia in the intensive care unit patients
Various electrolyte imbalances, including changes in magnesium levels, are characteristic of critically ill patients. However, routine measurement of magnesium concentration is often omitted, which may result in the development of hypomagnesemia. We conducted a review of the medical scientific data on this issue to present the current state of knowledge. To address the stated objectives, a scientific data search was performed in the eLIBRARY.RU and PubMed databases covering the period from 1975 to 2024. Articles in English and Russian were analyzed using the following keywords: “hypomagnesemia”, “electrolyte imbalance”, “potassium”, “sodium”, and “intensive care unit”. Full-text articles describing hypomagnesemia in critically ill adult patients in the general population, excluding obstetric conditions, were included in the analysis. The results of the analysis showed that in this patient category, hypomagnesemia is associated with increased mortality, higher incidence of sepsis, prolonged mechanical ventilation, longer hospital stays, and elevated one-year post-discharge mortality rates. In this regard, routine magnesium assessment should be mandatory for intensive care unit patients with gastrointestinal, endocrine, and cardiovascular diseases, as well as with acute kidney injury or exacerbation of chronic kidney disease. Further research is required to clarify the therapeutic role of magnesium in improving outcomes for critically ill patients.
- 12 August 2025
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 5 (4) , 168-178
Open AccessIssues of diagnosis and correction of hypomagnesemia in the intensive care unit patients
Various electrolyte imbalances, including changes in magnesium levels, are characteristic of critically ill patients. However, routine measurement of magnesium concentration is often omitted, which may result in the development of hypomagnesemia. We conducted a review of the medical scientific data on this issue to present the current state of knowledge. To address the stated objectives, a scientific data search was performed in the eLIBRARY.RU and PubMed databases covering the period from 1975 to 2024. Articles in English and Russian were analyzed using the following keywords: “hypomagnesemia”, “electrolyte imbalance”, “potassium”, “sodium”, and “intensive care unit”. Full-text articles describing hypomagnesemia in critically ill adult patients in the general population, excluding obstetric conditions, were included in the analysis. The results of the analysis showed that in this patient category, hypomagnesemia is associated with increased mortality, higher incidence of sepsis, prolonged mechanical ventilation, longer hospital stays, and elevated one-year post-discharge mortality rates. In this regard, routine magnesium assessment should be mandatory for intensive care unit patients with gastrointestinal, endocrine, and cardiovascular diseases, as well as with acute kidney injury or exacerbation of chronic kidney disease. Further research is required to clarify the therapeutic role of magnesium in improving outcomes for critically ill patients.
- Open Access
- 31 May 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 4 (1) , 29-37
The choice of enteral formula in patients in the acute period of critical ill with brain damage in the neurocritical care unit
Nutritional support is an important and integral part of the treatment process for critically ill patients. Patients after neurosurgical interventions and patients with damage to the central nervous system, for example, due to acute ischemic stroke, may be due to the severity of the condition in the intensive care unit. This is a separate category of patients and nutritional support for this category of patients has its own characteristics. Enteral nutrition, as the most physiological type of nutrition, should be an integral part of the treatment process in the intensive care unit. In patients in the acute period of a severe condition with brain damage, in addition to the metabolic response to damage, there are also factors that limit the implementation of enteral nutrition: the brain damage itself, being in intensive care, and methods of intensive therapy. The choice of an enteral formula in this category of patients is complex and fundamental to provide adequate nutritional support to cover energy and protein requirements. The purpose of this scientific review is to highlight the issues of choosing a mixture for enteral nutrition of patients in the neurocritical care unit who are in the acute period of a critical ill.
- 31 May 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 4 (1) , 29-37
Open AccessThe choice of enteral formula in patients in the acute period of critical ill with brain damage in the neurocritical care unit
Nutritional support is an important and integral part of the treatment process for critically ill patients. Patients after neurosurgical interventions and patients with damage to the central nervous system, for example, due to acute ischemic stroke, may be due to the severity of the condition in the intensive care unit. This is a separate category of patients and nutritional support for this category of patients has its own characteristics. Enteral nutrition, as the most physiological type of nutrition, should be an integral part of the treatment process in the intensive care unit. In patients in the acute period of a severe condition with brain damage, in addition to the metabolic response to damage, there are also factors that limit the implementation of enteral nutrition: the brain damage itself, being in intensive care, and methods of intensive therapy. The choice of an enteral formula in this category of patients is complex and fundamental to provide adequate nutritional support to cover energy and protein requirements. The purpose of this scientific review is to highlight the issues of choosing a mixture for enteral nutrition of patients in the neurocritical care unit who are in the acute period of a critical ill.
- Open Access
- 2 February 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 3 (4) , 207-216
Nutritional support as part of the basic therapy of a patient in the acute period of ischemic stroke in the intensive care unit
Ischemic stroke remains the predominant cause of disability in the population (3.2 per 1000 population). Only 8% of ischemic stroke survivors can return to their previous work. Nutritional support is an integral part of the multidisciplinary approach to the treatment of ischemic stroke in the intensive care unit during the acute and rehabilitation phases. Brain damage always has metabolic consequences on the patients body, and premorbid malnutrition and stroke-stroke malnutrition significantly affect disease outcomes. The incidence of malnutrition in patients with ischemic stroke varies widely, ranging from 6.1% to 62%, depending on the method for determining protein-energy malnutrition. Despite the relevance of the problem of nutritional support in patients with ischemic stroke, only a few specific recommendations are available in the literature for this category of patients. This review focuses on nutritional support for patients who require mechanical ventilation or admission in the intensive care unit for 48 h.
- 2 February 2023
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 3 (4) , 207-216
Open AccessNutritional support as part of the basic therapy of a patient in the acute period of ischemic stroke in the intensive care unit
Ischemic stroke remains the predominant cause of disability in the population (3.2 per 1000 population). Only 8% of ischemic stroke survivors can return to their previous work. Nutritional support is an integral part of the multidisciplinary approach to the treatment of ischemic stroke in the intensive care unit during the acute and rehabilitation phases. Brain damage always has metabolic consequences on the patients body, and premorbid malnutrition and stroke-stroke malnutrition significantly affect disease outcomes. The incidence of malnutrition in patients with ischemic stroke varies widely, ranging from 6.1% to 62%, depending on the method for determining protein-energy malnutrition. Despite the relevance of the problem of nutritional support in patients with ischemic stroke, only a few specific recommendations are available in the literature for this category of patients. This review focuses on nutritional support for patients who require mechanical ventilation or admission in the intensive care unit for 48 h.
- Open Access
- 23 August 2021
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 1 (4) , 190-196
Glycemic Control in Neurological Intensive Care Unit Patients
Critically ill patients often develop hyperglycemia because of the metabolic response to trauma and stress. In response to any form of damage to the organism, it reacts by increasing its own glucose production which subsequently causes hyperglycemia. This adaptive reaction of the organism is directed to aid in the rapid restoration after the damage. Therefore, glucose is an indispensable substrate in the critically ill which aids the reparation process. Severe and persistent hyperglycemia is associated with unfavorable outcomes and is considered to be an independent predictor of in-hospital mortality. The discussion remains on whether hyperglycemia is just a marker of increased stress which makes it a surrogate indicator of disease severity or if it is the reason for the unfavorable outcome. A few years ago, several published articles suggested that a tight glycemic control within the normal range improves treatment outcome. Over time, researchers have changed their point of view and currently there is a discussion on this matter in the scientific literatures. At the same time, the question of what glycemic level should be maintained for patients in the Neurological Intensive Care Unit is a matter of discussion. In this review, the authors analyzed the latest guidelines on treatment of critical patients with neurosurgical and neurological pathologies, specifically the glycemic control in this category of patients.
- 23 August 2021
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 1 (4) , 190-196
Open AccessGlycemic Control in Neurological Intensive Care Unit Patients
Critically ill patients often develop hyperglycemia because of the metabolic response to trauma and stress. In response to any form of damage to the organism, it reacts by increasing its own glucose production which subsequently causes hyperglycemia. This adaptive reaction of the organism is directed to aid in the rapid restoration after the damage. Therefore, glucose is an indispensable substrate in the critically ill which aids the reparation process. Severe and persistent hyperglycemia is associated with unfavorable outcomes and is considered to be an independent predictor of in-hospital mortality. The discussion remains on whether hyperglycemia is just a marker of increased stress which makes it a surrogate indicator of disease severity or if it is the reason for the unfavorable outcome. A few years ago, several published articles suggested that a tight glycemic control within the normal range improves treatment outcome. Over time, researchers have changed their point of view and currently there is a discussion on this matter in the scientific literatures. At the same time, the question of what glycemic level should be maintained for patients in the Neurological Intensive Care Unit is a matter of discussion. In this review, the authors analyzed the latest guidelines on treatment of critical patients with neurosurgical and neurological pathologies, specifically the glycemic control in this category of patients.
- Open Access
- 23 August 2021
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 1 (4) , 165-177
The Effects of Oral Nutritional Support on the Ability of the COVID-19 Patients to Recover: A Prospective, Open, Multicenter, Comparative in Two Groups, Observational Study
Background. Nutritional insufficiency and decreased muscle mass of patients diagnosed with COVID-19 leads to prolonged respiratory support, stay in ICU and hospital, as well as reduced muscle strength and quality of life in the recovery period after a viral pneumonia caused by COVID-19. Aims: To study the effects of oral nutritional support on the physical health recovery of COVID-19 patients. Materials and methods. A prospective, open, multicenter, comparative observative study of two groups, observational study was initiated to evaluate the effects of oral nutritional support (ONS) by Nutridrink 200 ml on the ability of COVID-19 patients to recover. The patients with these criteria were included in the study: aged 1869; a confirmed COVID-19 infection; requires respiratory support; ability to consume more than 60% of food from the total required; presence of a signed consent form. One group received supplementary oral nutritional support (ONS) everyday for 28 days from the day of inclusion. The other group received standard diet. The primary endpoint was the evaluation of quality of life using the SF-36 questionnaire and the changes in the hand grip strength between the 3rd and 1st visits. Secondary endpoints of the study were length of stay in hospital and duration of respiratory support in the hospital. Results. 205 patients with a COVID-19 infection were included in the study. The final number of patients included in the study was 185 patients. Median age was 55 years old. The majority of patients were male 57.84% (107 patients). Upon evaluation of the physical component of quality of life using the SF-36 questionnaire, we obtained a statistically significant difference between the control and study groups on the 4th visit 44.285.45 and 46.586.76 respectively (p=0.012). Muscle strength was statistically different in the control (4.011.15 daN) and study (6.12.06 daN) groups (p 0.0001). The duration of respiratory support was significantly lower in the study group, 6.71.30 days as opposed to 8.141.52 days in the control group (p 0.0001). Also, in the group with oral nutritional support, there was a statistically significant decrease in the length of stay in hospital. In the control group, the average length of stay in hospital was 16.472.93 days, whereas in the study group it was 13.162.69 days (p 0.0001). Conclusion. Oral nutritional support given to oxygen dependent COVID-19 patients improves rehabilitation potential including preservation of muscle mass and function, reducing oxygen support requirements and length of stay in hospital.
- 23 August 2021
- Published by ECO-Vector LLC in Clinical nutrition and metabolism
- Vol. 1 (4) , 165-177
Open AccessThe Effects of Oral Nutritional Support on the Ability of the COVID-19 Patients to Recover: A Prospective, Open, Multicenter, Comparative in Two Groups, Observational Study
Background. Nutritional insufficiency and decreased muscle mass of patients diagnosed with COVID-19 leads to prolonged respiratory support, stay in ICU and hospital, as well as reduced muscle strength and quality of life in the recovery period after a viral pneumonia caused by COVID-19. Aims: To study the effects of oral nutritional support on the physical health recovery of COVID-19 patients. Materials and methods. A prospective, open, multicenter, comparative observative study of two groups, observational study was initiated to evaluate the effects of oral nutritional support (ONS) by Nutridrink 200 ml on the ability of COVID-19 patients to recover. The patients with these criteria were included in the study: aged 1869; a confirmed COVID-19 infection; requires respiratory support; ability to consume more than 60% of food from the total required; presence of a signed consent form. One group received supplementary oral nutritional support (ONS) everyday for 28 days from the day of inclusion. The other group received standard diet. The primary endpoint was the evaluation of quality of life using the SF-36 questionnaire and the changes in the hand grip strength between the 3rd and 1st visits. Secondary endpoints of the study were length of stay in hospital and duration of respiratory support in the hospital. Results. 205 patients with a COVID-19 infection were included in the study. The final number of patients included in the study was 185 patients. Median age was 55 years old. The majority of patients were male 57.84% (107 patients). Upon evaluation of the physical component of quality of life using the SF-36 questionnaire, we obtained a statistically significant difference between the control and study groups on the 4th visit 44.285.45 and 46.586.76 respectively (p=0.012). Muscle strength was statistically different in the control (4.011.15 daN) and study (6.12.06 daN) groups (p 0.0001). The duration of respiratory support was significantly lower in the study group, 6.71.30 days as opposed to 8.141.52 days in the control group (p 0.0001). Also, in the group with oral nutritional support, there was a statistically significant decrease in the length of stay in hospital. In the control group, the average length of stay in hospital was 16.472.93 days, whereas in the study group it was 13.162.69 days (p 0.0001). Conclusion. Oral nutritional support given to oxygen dependent COVID-19 patients improves rehabilitation potential including preservation of muscle mass and function, reducing oxygen support requirements and length of stay in hospital.